# OnCo record nct03934372 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03934372/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03934372", "NCT03934372" ;
  schema:name "Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of Ponatinib in acute myeloid leukaemia, chronic myeloid leukaemia, acute lymphoblastic leukaemia and non-Hodgkin lymphoma, run by Incyte Biosciences International Sàrl, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03934372/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03934372> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2020-01-29" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/cml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/all-paediatric-relapsed/>, <https://onco.cc/cancers/aml-paediatric/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/ponatinib/> ;
  onco:companies <https://onco.cc/companies/incyte/> .